MIKAELA PERRELLI: Open Payments
NPI 1992376503 · ORANGE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 19 payments from 11 companies in 2025. Trend: 2023 $242 · 2024 $235 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 4 | $186 |
| Astellas Pharma US Inc | 3 | $91 |
| Organon LLC | 2 | $60 |
| Exact Sciences Corporation | 2 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Sage Therapeutics, LLC | 1 | $32 |
| ABBVIE INC. | 1 | $30 |
| Exeltis, USA Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| CooperSurgical, Inc. | 1 | $19 |
Products named: BIJUVA, Veozah, Cologuard Collection Kit, MYFEMBREE, NEXPLANON, ZURZUVAE, LO LOESTRIN FE, SLYND.
Industry payments across CT — which companies pay providers there.
